Similar articles for PMID: 23885217

Year	Number of Results
1993	1
1995	2
1996	1
1999	1
2000	2
2002	1
2003	3
2004	3
2005	2
2008	2
2009	3
2010	3
2011	4
2012	8
2013	8
2014	2
2015	10
2016	4
2017	6
2018	6
2019	13
2020	13
2021	2
2022	2
2024	0

1

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Yokota SJ, Facciponte JG, Kelleher RJ Jr, Shultz LD, Loyall JL, Parsons RR, Odunsi K, Frelinger JG, Lord EM, Gerber SA, Balu-Iyer SV, Bankert RB. Yokota SJ, et al. Cancer Immun. 2013 May 31;13:11. Print 2013. Cancer Immun. 2013. PMID: 23885217 Free PMC article.

2

An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.

Gitto SB, Kim H, Rafail S, Omran DK, Medvedev S, Kinose Y, Rodriguez-Garcia A, Flowers AJ, Xu H, Schwartz LE, Powell DJ Jr, Simpkins F. Gitto SB, et al. Gynecol Oncol. 2020 Jan;156(1):222-232. doi: 10.1016/j.ygyno.2019.10.011. Epub 2019 Dec 7. Gynecol Oncol. 2020. PMID: 31818495

3

The peritoneal tumour microenvironment of high-grade serous ovarian cancer.

Leinster DA, Kulbe H, Everitt G, Thompson R, Perretti M, Gavins FN, Cooper D, Gould D, Ennis DP, Lockley M, McNeish IA, Nourshargh S, Balkwill FR. Leinster DA, et al. J Pathol. 2012 Jun;227(2):136-45. doi: 10.1002/path.4002. Epub 2012 Apr 18. J Pathol. 2012. PMID: 22322968 Free PMC article.

4

Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.

Bhatta M, Shenoy GN, Loyall JL, Gray BD, Bapardekar M, Conway A, Minderman H, Kelleher RJ Jr, Carreno BM, Linette G, Shultz LD, Odunsi K, Balu-Iyer SV, Pak KY, Bankert RB. Bhatta M, et al. J Immunother Cancer. 2021 Oct;9(10):e003148. doi: 10.1136/jitc-2021-003148. J Immunother Cancer. 2021. PMID: 34599030 Free PMC article.

5

Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.

Simpson-Abelson MR, Sonnenberg GF, Takita H, Yokota SJ, Conway TF Jr, Kelleher RJ Jr, Shultz LD, Barcos M, Bankert RB. Simpson-Abelson MR, et al. J Immunol. 2008 May 15;180(10):7009-18. doi: 10.4049/jimmunol.180.10.7009. J Immunol. 2008. PMID: 18453623

6

Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor.

Schutsky K, Song DG, Lynn R, Smith JB, Poussin M, Figini M, Zhao Y, Powell DJ Jr. Schutsky K, et al. Oncotarget. 2015 Oct 6;6(30):28911-28. doi: 10.18632/oncotarget.5029. Oncotarget. 2015. PMID: 26359629 Free PMC article.

7

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.

Khan AN, Kolomeyevskaya N, Singel KL, Grimm MJ, Moysich KB, Daudi S, Grzankowski KS, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH. Khan AN, et al. Oncotarget. 2015 May 10;6(13):11310-26. doi: 10.18632/oncotarget.3597. Oncotarget. 2015. PMID: 25888637 Free PMC article.

8

Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.

Deng W, Gu X, Lu Y, Gu C, Zheng Y, Zhang Z, Chen L, Yao Z, Li LY. Deng W, et al. Angiogenesis. 2012 Mar;15(1):71-85. doi: 10.1007/s10456-011-9244-y. Epub 2011 Dec 31. Angiogenesis. 2012. PMID: 22210436

9

Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.

Voutsas IF, Pistamaltzian N, Tsiatas ML, Skopeliti M, Katsila T, Mavrothalassiti I, Spyrou S, Dimopoulos MA, Tsitsilonis OE, Bamias A. Voutsas IF, et al. Eur J Cancer. 2013 May;49(7):1706-14. doi: 10.1016/j.ejca.2012.11.037. Epub 2012 Dec 28. Eur J Cancer. 2013. PMID: 23276721

10

CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.

Zhang QF, Li J, Jiang K, Wang R, Ge JL, Yang H, Liu SJ, Jia LT, Wang L, Chen BL. Zhang QF, et al. Theranostics. 2020 Aug 25;10(23):10619-10633. doi: 10.7150/thno.44871. eCollection 2020. Theranostics. 2020. PMID: 32929370 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year